Massimiliano Gnecchi researcher
Gnecchi, Massimiliano
VIAF ID: 191146936720013781598 (Personal)
Permalink: http://viaf.org/viaf/191146936720013781598
Preferred Forms
- 100 1 _ ‡a Gnecchi, Massimiliano
- 100 1 _ ‡a Gnecchi, Massimiliano
- 100 1 _ ‡a Gnecchi, Massimiliano
- 100 0 _ ‡a Massimiliano Gnecchi ‡c researcher
4xx's: Alternate Name Forms (2)
Works
Title | Sources |
---|---|
Allogeneic lethally irradiated cord blood mononuclear cells in no-option critical limb ischemia: a "box of rain". | |
Cell Therapy for Heart Regeneration: Learning from the Past to Build a Brighter Future | |
Combination of miRNA499 and miRNA133 exerts a synergic effect on cardiac differentiation. | |
Cytokine-induced mobilization of circulating endothelial progenitor cells enhances repair of injured arteries | |
Different pro-angiogenic potential of γ-irradiated PBMC-derived secretome and its subfractions | |
Early Complete Revascularization in Hemodynamically Stable Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease | |
Effectiveness of adjunctive stent implantation following directional coronary atherectomy for treatment of left anterior descending ostial stenosis | |
Enhancing stem cell therapy through genetic modification | |
Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement | |
Favorable effect of glycoprotein IIbIIIa inhibitors among STEMI patients treated with primary PCI and incomplete ST resolution | |
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi005-A from a patient carrying the KCNQ1-R190W mutation | |
Heme oxygenase-1 (HO-1) inhibits postmyocardial infarct remodeling and restores ventricular function | |
Human mesenchymal stromal cells do not express ACE2 and TMPRSS2 and are not permissive to SARS-CoV-2 infection | |
Identification of a targeted and testable antiarrhythmic therapy for long-QT syndrome type 2 using a patient-specific cellular model. | |
Induced pluripotent stem cell technology: Toward the future of cardiac arrhythmias | |
The KCNH2-IVS9-28A/G mutation causes aberrant isoform expression and hERG trafficking defect in cardiomyocytes derived from patients affected by Long QT Syndrome type 2. | |
Long QT Syndrome Modelling with Cardiomyocytes Derived from Human-induced Pluripotent Stem Cells | |
Mesenchymal stem cell therapy for heart disease. | |
Mesenchymal Stem Cells : Methods and Protocols | |
Mesenchymal stem cells overexpressing Akt dramatically repair infarcted myocardium and improve cardiac function despite infrequent cellular fusion or differentiation | |
microRNA and Cardiac Regeneration. | |
Molecular and cell-based therapies for protection, rescue, and repair of ischemic myocardium: reasons for cautious optimism. | |
NOS1AP polymorphisms reduce NOS1 activity and interact with prolonged repolarization in arrhythmogenesis | |
Novel mitochondrial protein interactors of immunoglobulin light chains causing heart amyloidosis. | |
Optimized lentiviral transduction of human amniotic mesenchymal stromal cells. | |
Paracrine factors of human fetal MSCs inhibit liver cancer growth through reduced activation of IGF-1R/PI3K/Akt signaling | |
Prognostic Impact of in-Hospital-Bleeding in Patients With ST-Elevation Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention. | |
Proteotoxicity in cardiac amyloidosis: amyloidogenic light chains affect the levels of intracellular proteins in human heart cells | |
Rat experimental model of myocardial ischemia/reperfusion injury: an ethical approach to set up the analgesic management of acute post-surgical pain | |
Secreted frizzled related protein 2 (Sfrp2) is the key Akt-mesenchymal stem cell-released paracrine factor mediating myocardial survival and repair | |
Smoker's paradox in ST-elevation myocardial infarction: Role of inflammation and platelets | |
Strategies for reducing door to balloon time in patients with acute myocardial infarction undergoing primary angioplasty: the Pavia experience | |
Synthetic extracellular matrix mimic hydrogel improves efficacy of mesenchymal stromal cell therapy for ischemic cardiomyopathy. | |
Testing the Paracrine Properties of Human Mesenchymal Stem Cells Using Conditioned Medium. | |
Therapeutic potential of endothelial progenitor cells in cardiovascular diseases. | |
The Unstoppable Attraction for Induced Pluripotent Stem Cells | |
Vagal stimulation, through its nicotinic action, limits infarct size and the inflammatory response to myocardial ischemia and reperfusion. |